Investors Purchase Large Volume of Call Options on Tilray (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY) saw some unusual options trading on Tuesday. Stock traders bought 210,378 call options on the company. This represents an increase of 266% compared to the typical volume of 57,539 call options.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Alliance Global Partners raised their price objective on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research note on Friday, April 5th. CIBC reduced their price objective on Tilray from $2.25 to $2.00 and set a “neutral” rating for the company in a research note on Wednesday, April 10th. Finally, Canaccord Genuity Group reduced their price objective on Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th.

Institutional Investors Weigh In On Tilray

Institutional investors and hedge funds have recently modified their holdings of the company. Clear Street Markets LLC purchased a new stake in shares of Tilray in the 3rd quarter valued at $25,000. Lake Street Financial LLC acquired a new position in Tilray during the 3rd quarter worth $28,000. Gainplan LLC acquired a new position in Tilray during the 4th quarter worth $28,000. Simplicity Wealth LLC acquired a new position in Tilray during the 1st quarter worth $28,000. Finally, RPO LLC acquired a new position in Tilray during the 4th quarter worth $28,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Stock Performance

Shares of Tilray stock opened at $2.02 on Thursday. Tilray has a one year low of $1.50 and a one year high of $3.40. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. The company has a market cap of $1.56 billion, a price-to-earnings ratio of -4.59 and a beta of 2.36. The business’s 50 day moving average price is $1.97 and its 200 day moving average price is $1.94.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.